IL2 and Burkitt lymphoma: While not inducing cytotoxicity on its own, IL-2 increased Vδ2 γδTc lysis of Daudi Burkitt’s lymphoma and TU167 squamous carcinoma cell lines in a dose-dependent manner in the presence of tumor cells or phosphoantigen (31).